The aim of this study was to use a meta-analysis to determine any association between WT1 expression status and overall survival (OS), leukemia-free survival (LFS), and cumulative incidence of relapse (CIR) for patients with MDS. The gene discussed is WT1; the disease is myelodysplastic syndrome.